{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:08:05Z","timestamp":1784207285260,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.revmed.2021.10.004","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:36:00Z","timestamp":1639010160000},"page":"301-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Maladies immunologiques et h\u00e9matologiques li\u00e9es \u00e0 HHV-8"],"prefix":"10.1016","volume":"43","author":[{"given":"F.","family":"Blaison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Galtier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Parrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-F.","family":"Viallard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Boutboul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.revmed.2021.10.004_bib0300","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1172\/JCI44185","article-title":"KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation","volume":"121","author":"Hassman","year":"2011","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.revmed.2021.10.004_bib0305","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0060-9","article-title":"Kaposi sarcoma","volume":"5","author":"Cesarman","year":"2019","journal-title":"Nat Rev Dis Primer"},{"issue":"4","key":"10.1016\/j.revmed.2021.10.004_bib0310","doi-asserted-by":"crossref","first-page":"e1006967","DOI":"10.1371\/journal.ppat.1006967","article-title":"KSHV induces immunoglobulin rearrangements in mature B lymphocytes","volume":"14","author":"Totonchy","year":"2018","journal-title":"PLOS Pathog"},{"issue":"5","key":"10.1016\/j.revmed.2021.10.004_bib0315","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.medmal.2005.02.009","article-title":"Aspects \u00e9pid\u00e9miologiques de l\u2019herp\u00e8svirus humain 8 (HHV-8) et du sarcome de Kaposi","volume":"35","author":"Plancoulaine","year":"2005","journal-title":"Med Mal Infect"},{"issue":"2","key":"10.1016\/j.revmed.2021.10.004_bib0320","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/bjh.15019","article-title":"The full spectrum of Castleman disease: 273\u00a0patients studied over 20\u00a0years","volume":"180","author":"Oksenhendler","year":"2018","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.revmed.2021.10.004_bib0325","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","article-title":"Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease","volume":"86","author":"Soulier","year":"1995","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.revmed.2021.10.004_bib0330","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/annonc\/mdn697","article-title":"The role of immune suppression and HHV-8\u00a0in the increasing incidence of HIV-associated multicentric Castleman's disease","volume":"20","author":"Powles","year":"2009","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.revmed.2021.10.004_bib0335","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1183\/09031936.05.00130304","article-title":"Pulmonary manifestations of multicentric Castleman's disease in HIV infection: a clinical, biological and radiological study","volume":"26","author":"Guihot","year":"2005","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.revmed.2021.10.004_bib0340","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1182\/bloodadvances.2020004058","article-title":"Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases","volume":"5","author":"Ramaswami","year":"2021","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.revmed.2021.10.004_bib0345","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/bjh.14152","article-title":"Autoimmune thrombotic thrombocytopenic purpura associated with HHV8-related Multicentric Castleman disease","volume":"178","author":"London","year":"2017","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.revmed.2021.10.004_bib0350","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/bloodadvances.2020002801","article-title":"Autoimmune hypoglycemia expands the biological spectrum of HHV8+ multicentric Castleman disease","volume":"5","author":"Arnautou","year":"2021","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.revmed.2021.10.004_bib0355","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s00259-008-0998-4","article-title":"FDG-PET\/CT imaging in the management of HIV-associated multicentric Castleman's disease","volume":"36","author":"Barker","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.revmed.2021.10.004_bib0360","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/infdis\/jiv204","article-title":"18F-fluorodeoxyglucose positron emission tomography in kaposi sarcoma herpesvirus\u2013associated multicentric castleman disease: correlation with activity, severity, inflammatory and virologic parameters","volume":"212","author":"Polizzotto","year":"2015","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.revmed.2021.10.004_bib0365","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood.V96.6.2069.h8002069_2069_2073","article-title":"High levels of human herpesvirus 8\u00a0viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients","volume":"96","author":"Oksenhendler","year":"2000","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.revmed.2021.10.004_bib0370","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/blood-2011-02-335620","article-title":"Plasma HHV8\u00a0DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease","volume":"118","author":"Stebbing","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.revmed.2021.10.004_bib0375","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1182\/blood.V97.7.2130","article-title":"Kaposi sarcoma-associated herpesvirus infects monotypic (IgMlambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders","volume":"97","author":"Du","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.revmed.2021.10.004_bib0380","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2559.2008.03144.x","article-title":"Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD): immunophenotype of KSHV+ cells in HIV+ MCD","volume":"53","author":"Chadburn","year":"2008","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.revmed.2021.10.004_bib0385","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ajh.10022","article-title":"Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review","volume":"69","author":"Larroche","year":"2002","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.revmed.2021.10.004_bib0390","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood-2011-08-376012","article-title":"Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease","volume":"119","author":"G\u00e9rard","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.revmed.2021.10.004_bib0395","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood.V99.7.2331","article-title":"High incidence of Kaposi sarcoma\u2013associated herpesvirus\u2013related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease","volume":"99","author":"Oksenhendler","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.revmed.2021.10.004_bib0400","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1182\/bloodadvances.2020004058","article-title":"Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases","volume":"5","author":"Ramaswami","year":"2021","journal-title":"Blood Adv"},{"issue":"25","key":"10.1016\/j.revmed.2021.10.004_bib0405","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood.2019004602","article-title":"Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus\u2013associated multicentric Castleman disease","volume":"135","author":"Ramaswami","year":"2020","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.revmed.2021.10.004_bib0410","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1200\/JCO.2007.10.6732","article-title":"Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus\u2013associated multicentric Castleman's Disease: ANRS 117\u00a0CastlemaB Trial","volume":"25","author":"G\u00e9rard","year":"2007","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.revmed.2021.10.004_bib0415","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/0003-4819-147-12-200712180-00003","article-title":"Brief communication: rituximab in HIV-associated multicentric castleman disease","volume":"147","author":"Bower","year":"2007","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.revmed.2021.10.004_bib0420","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1182\/blood-2014-07-586800","article-title":"Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease","volume":"124","author":"Uldrick","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2021.10.004_bib0425","unstructured":"PNDS - Recommandations Maladie de Castleman - MaRIH - Fili\u00e8re de sant\u00e9 Maladies Rares Immuno-H\u00e9matologiques [Internet]. MaRIH [cited 2021\u00a0Jul 10]; Available from: https:\/\/marih.fr\/documentation\/pnds_recommandations\/pnds_recommandations_maladie_de_castleman\/."},{"issue":"26","key":"10.1016\/j.revmed.2021.10.004_bib0430","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1182\/blood-2010-11-317610","article-title":"High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy","volume":"117","author":"Uldrick","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.revmed.2021.10.004_bib0435","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/654798","article-title":"An Interleukin-6-related systemic inflammatory syndrome in patients co-infected with kaposi sarcoma-associated herpesvirus and hiv but without multicentric castleman disease","volume":"51","author":"Uldrick","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.revmed.2021.10.004_bib0440","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/cid\/civ996","article-title":"Clinical features and outcomes of patients with symptomatic kaposi sarcoma herpesvirus (KSHV)-associated inflammation: prospective characterization of KSHV inflammatory cytokine syndrome (KICS)","volume":"62","author":"Polizzotto","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2021.10.004_bib0445","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fmicb.2012.00073","article-title":"Clinical manifestations of kaposi sarcoma herpesvirus lytic activation: multicentric castleman disease (KSHV-MCD) and the KSHV inflammatory cytokine syndrome","volume":"3","author":"Polizzotto","year":"2012","journal-title":"Front Microbiol"},{"issue":"11","key":"10.1016\/j.revmed.2021.10.004_bib0450","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1111\/ajt.14346","article-title":"Successful treatment of kaposi sarcoma-associated herpesvirus inflammatory cytokine syndrome after kidney-liver transplant: correlations with the human herpesvirus 8\u00a0miRNome and Specific T Cell Response","volume":"17","author":"Mularoni","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.revmed.2021.10.004_bib0455","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1182\/asheducation-2013.1.103","article-title":"Human herpesvirus-8: Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma","volume":"2013","author":"Kaplan","year":"2013","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.revmed.2021.10.004_bib0460","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1182\/blood.V73.3.792.bloodjournal733792","article-title":"Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus","volume":"73","author":"Knowles","year":"1989","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.revmed.2021.10.004_bib0465","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","article-title":"Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus","volume":"88","author":"Nador","year":"1996","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.revmed.2021.10.004_bib0470","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood-2019-01-893339","article-title":"Viral, immunologic, and clinical features of primary effusion lymphoma","volume":"133","author":"Lurain","year":"2019","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.revmed.2021.10.004_bib0475","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2012-04-421412","article-title":"How I treat HHV8\/KSHV-related diseases in posttransplant patients","volume":"120","author":"Riva","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.revmed.2021.10.004_bib0480","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1634\/theoncologist.12-5-569","article-title":"Primary effusion lymphoma","volume":"12","author":"Chen","year":"2007","journal-title":"Oncologist"},{"issue":"18","key":"10.1016\/j.revmed.2021.10.004_bib0485","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1182\/blood-2018-03-791426","article-title":"Biology and management of primary effusion lymphoma","volume":"132","author":"Shimada","year":"2018","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.revmed.2021.10.004_bib0490","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.3109\/10428194.2012.694075","article-title":"Prognosis in primary effusion lymphoma is associated with the number of body cavities involved","volume":"53","author":"Castillo","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.revmed.2021.10.004_bib0495","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1309\/AJCPULI3W6WUGGPY","article-title":"Diverse clinicopathologic features in human herpesvirus 8\u2013associated lymphomas lead to diagnostic problems","volume":"142","author":"Courville","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"18","key":"10.1016\/j.revmed.2021.10.004_bib0500","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1182\/bloodadvances.2020002293","article-title":"Primary human herpesvirus 8\u2013negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis","volume":"4","author":"Kaji","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.revmed.2021.10.004_bib0505","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412","article-title":"HHV-8\u00a0is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma","volume":"95","author":"Dupin","year":"2000","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.revmed.2021.10.004_bib0510","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood.V99.7.2331","article-title":"High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease","volume":"99","author":"Oksenhendler","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.revmed.2021.10.004_bib0515","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1182\/blood.V97.7.2130","article-title":"Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders","volume":"97","author":"Du","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.revmed.2021.10.004_bib0520","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41379-019-0365-y","article-title":"KSHV\/HHV8-positive large B-cell lymphomas and associated diseases: a heterogeneous group of lymphoproliferative processes with significant clinicopathological overlap","volume":"33","author":"Vega","year":"2020","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.revmed.2021.10.004_bib0525","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/ajcp\/aqw218","article-title":"HHV8\/KSHV-positive lymphoproliferative disorders and the spectrum of plasmablastic and plasma cell neoplasms: 2015\u00a0SH\/EAHP Workshop Report\u2014Part 3","volume":"147","author":"Chadburn","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.revmed.2021.10.004_bib0530","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/modpathol.2016.233","article-title":"HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma","volume":"30","author":"Gonzalez-Farre","year":"2017","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.revmed.2021.10.004_bib0535","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/PAS.0000000000000823","article-title":"KSHV-associated and EBV-associated Germinotropic Lymphoproliferative Disorder: new findings and review of the literature","volume":"41","author":"Bhavsar","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.revmed.2021.10.004_bib0540","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2002-02-0487","article-title":"KSHV- and EBV-associated germinotropic lymphoproliferative disorder","volume":"100","author":"Du","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.revmed.2021.10.004_bib0545","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/his.13428","article-title":"Lymphoproliferative disorders with concurrent HHV8\u00a0and EBV infection: beyond primary effusion lymphoma and germinotropic lymphoproliferative disorder","volume":"72","author":"Wang","year":"2018","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.revmed.2021.10.004_bib0550","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/pin.12951","article-title":"Human herpesvirus 8-positive multicentric Castleman disease with germinotropic plasmablastic aggregates: overlapping spectrum of human herpesvirus 8-associated lymphoproliferative disorder","volume":"70","author":"Nakaya","year":"2020","journal-title":"Pathol Int"},{"issue":"19","key":"10.1016\/j.revmed.2021.10.004_bib0555","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1200\/JCO.2005.07.084","article-title":"Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS","volume":"23","author":"Boulanger","year":"2005","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.revmed.2021.10.004_bib0560","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1182\/blood.2021011649","article-title":"Simultaneous occurrence of KSHV-associated malignancies in a patient affected by HIV","volume":"137","author":"Vaccher","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.revmed.2021.10.004_bib0565","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ajh.24251","article-title":"Classic and extracavitary primary effusion lymphoma in 51\u00a0HIV-infected patients from a single institution","volume":"91","author":"Guillet","year":"2016","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.revmed.2021.10.004_bib0570","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/PAS.0000000000000823","article-title":"KSHV-associated and EBV-associated germinotropic lymphoproliferative disorder: new findings and review of the literature","volume":"41","author":"Bhavsar","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.revmed.2021.10.004_bib0575","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1086\/375224","article-title":"Human herpesvirus 8-associated hemophagocytic lymphohistiocytosis in human immunodeficiency virus-infected patients","volume":"37","author":"Fardet","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.revmed.2021.10.004_bib0580","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200011093431905","article-title":"Bone marrow failure associated with human herpesvirus 8\u00a0infection after transplantation","volume":"343","author":"Luppi","year":"2000","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.revmed.2021.10.004_bib0585","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2012-04-421412","article-title":"treat HHV8\/KSHV-related diseases in posttransplant patients","volume":"120","author":"Riva","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.revmed.2021.10.004_bib0295","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/art.40217","article-title":"Brief report: de novo human herpesvirus 8\u00a0tumors induced by rituximab in autoimmune or inflammatory systemic diseases","volume":"69","author":"P\u00e9rier","year":"2017","journal-title":"Arthritis Rheumatol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866321007104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866321007104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:44:44Z","timestamp":1759337084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866321007104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0248866321007104"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2021.10.004","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maladies immunologiques et h\u00e9matologiques li\u00e9es \u00e0 HHV-8","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2021.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}